Suppr超能文献

肠道微生物群调节:对感染控制和抗菌药物管理的影响。

Gut Microbiota Modulation: Implications for Infection Control and Antimicrobial Stewardship.

机构信息

National Centre for Infectious Diseases, Singapore, Singapore.

Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore, Singapore.

出版信息

Adv Ther. 2020 Oct;37(10):4054-4067. doi: 10.1007/s12325-020-01458-z. Epub 2020 Aug 7.

Abstract

The human microbiome comprises a complex ecosystem of microbial communities that exist within the human body, the largest and most diverse of which are found within the human intestine. It has been increasingly implicated in human health and diseases, demonstrably playing a critical role in influencing host immune response, protection against pathogen overgrowth, biosynthesis, and metabolism. As our understanding of the links between the gut microbiota with host immunity and infectious diseases deepens, there is a greater need to incorporate methods of modulating it as a means of therapy or infection prevention in daily clinical practice. Traditional antimicrobial stewardship principles have been evaluated to assess their impact on the gut microbiota diversity and the consequent repercussions, taking into consideration antibiotic pharmacokinetic and pharmacodynamic properties. Novel strategies of selective digestive decontamination and fecal microbiota transplantation to regulate the gut microbiota have also been tested in different conditions with variable results. This review seeks to provide an overview of the available literature on the modulation of the gut microbiota and its implications for infection control and antimicrobial stewardship. With increased understanding, gut microbiota profiling through metataxonomic analysis may provide further insight into modulating microbial communities in the context of infection prevention and control.

摘要

人类微生物组由存在于人体内部的微生物群落组成的复杂生态系统构成,其中最大和最多样化的微生物群落在人类肠道内。它越来越多地与人类健康和疾病有关,明显在影响宿主免疫反应、防止病原体过度生长、生物合成和代谢方面发挥着关键作用。随着我们对肠道微生物群与宿主免疫和传染病之间联系的理解不断加深,在日常临床实践中,需要将调节肠道微生物群作为治疗或感染预防的手段的方法不断增加。已经评估了传统的抗菌药物管理原则,以评估它们对肠道微生物群多样性的影响及其带来的后果,同时考虑了抗生素药代动力学和药效学特性。选择性消化道去污染和粪便微生物移植等调节肠道微生物群的新策略已在不同条件下进行了测试,但结果存在差异。本文综述了关于调节肠道微生物群及其对感染控制和抗菌药物管理的影响的现有文献。随着认识的提高,通过宏基因组分析进行肠道微生物群分析可能会为预防和控制感染方面的微生物群落调节提供更多的见解。

相似文献

引用本文的文献

4
7
Interactions-based classification of a single microbial sample.基于相互作用的单个微生物样本分类。
Cell Rep Methods. 2024 May 20;4(5):100775. doi: 10.1016/j.crmeth.2024.100775. Epub 2024 May 13.

本文引用的文献

2
Aging progression of human gut microbiota.人类肠道微生物组的衰老进程。
BMC Microbiol. 2019 Oct 28;19(1):236. doi: 10.1186/s12866-019-1616-2.
10
The human microbiota and infection prevention.人体微生物组与感染预防。
Infect Control Hosp Epidemiol. 2019 May;40(5):585-589. doi: 10.1017/ice.2019.28. Epub 2019 Feb 19.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验